newsfilter
← Latest News
GlobeNewswire·

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

$12.5 million in second quarter PYRUKYND® (mitapivat) net revenues; ended second quarter with $1.3 billion dollars in cash, cash equivalents and marketable securitiesPYRUKYND sNDA for thalassemia under active